‘Will strengthen commercial roll-out of Sputnik V vaccine in India in coming weeks’, assures Dr Reddy’s Laboratories | India News

‘Will strengthen commercial roll-out of Sputnik V vaccine in India in coming weeks’, assures Dr Reddy’s Laboratories | India News


NEW DELHI: Dr Reddy’s Laboratories on Monday issued a statement assuring that it will strengthen the commercial roll-out of Sputnik V vaccines in India in the coming weeks.
It further stated that neither the ongoing soft commercial launch nor work towards its ramp-up in India have been put on hold.

Starting initially in Hyderabad, the soft launch roll-out of Sputnik V has scaled up speedily and reached cities and towns all over India – including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik, Coimbatore, Ranchi, Jaipur, Lucknow, Patna, Bhubaneshwar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot, Palakkad, Allahabad, Dimapur, Kohima, Indore, Bhopal, Surat, Cuttack, Dharwad, Ernakulum, Ratlam, Faridabad, Srinagar, Gandhinagar, Vadodara, Gulbarga, Madurai, Guntur, Kannur, Jabalpur, Jalandhar, Kanpur, Mysore,” read Dr Reddy’s Laboratories statement.
The Sputnik V vaccine was launched on a soft pilot basis in India on May 14, 2021. The nationwide soft launch of Sputnik V has reached over 50 cities and towns across India.
Dr Reddy’s has partnered with major hospitals across the country for this purpose, all of whom have successfully administered Sputnik V in India, including ongoing commercial roll-outs to the public.
(With inputs from agencies)





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *